WhyNow that we have reached the halfway mark in October we still do not have any idea of what is really going on with this company. Marching quickly through the 4th quarter of 2021 and so many unanswered questions.
The biggest question for me is what is the hold up with this Dermal Injector ? With the testing beginning in May I can accept they are not finished with the testing process but surely to God they could give us some update on how the testing is going and when they hope to apply for FDA Approval. I hate to think this because I have a truckload of shares but is there something wrong with the device which is holding up applying for FDA Approval ?
We have also heard for years they are working on a resolution to the disagreement with Shiseido. I am beginning to think there is nothing going on. Shiseido has long since blown Replicel off in this regard knowing Replicel does not have the resources to take them to court to resolve this dispute. So where does this leave us with Replicel's biggest stem cell asset: RCH-01. Nowhere. If Shiseido has gone off on their own with hair follicle stem cell research we don't hear any mention of Replicel's contingency plan to move forward with their own research. If and when Shiseido takes it's product to market you can be assured they will not be recognizing the original contract.
Thirdly why have the RCT-01 and RCS-01 trials not begun in China ? Yofoto has long since built their research lab where these trials would be performed. We have heard for years about applications to stage these trials but yet nothing ever happens.
I could go on but I think you get the picture. We are overdue for some sort of an update. What is worse: bad news or no news. I think at this point I would take bad news, at least I would have some sense of what is going on with this company.